Abstract:Ascorbate (Asc) increases the Km value of indoleamine 2,3‐dioxygenase (IDO). However, why do structurally very different molecules compete with each other? Here, a possible scheme of competition between Asc and L‐Trp is proposed. The FeII–O2 IDO can repeat the dioxygenase reaction as long as it reacts with L‐Trp. On the other hand, substrate‐free FeII–O2 IDO is converted into inactive FeIII–IDO by autoxidation, and Asc promotes the autoxidation. Indoleamine 2,3‐dioxygenase (IDO) is a monomeric heme enzyme that catalyzes the oxidative cleavage of tryptophan (L‐Trp) to form N‐formyl‐kynurenine. Similar to other heme proteins, IDO only binds to O2 when the heme iron is ferrous (FeII), thereby rendering the enzyme active. Thus, ascorbate (Asc, a reducing agent) and methylene blue (MB, an electron carrier) are commonly added to in vitro IDO assay systems. However, Asc and MB have been recently reported to significantly impact the measurement of the enzymatic parameters of vertebrate IDO. Aspergillus fumigatus is a filamentous fungus and the most common cause of invasive aspergillosis; it has three IDO genes (IDOα, IDOβ, and IDOγ). The FeII–O2 IDOs of A. fumigatus, particularly FeII–O2 IDOγ, have relatively long half‐lives in their autoxidation; however, the autoxidation was accelerated by Asc. Similar to vertebrate IDOs, Asc acted as a competitive (or mixed‐competitive) inhibitor of the IDOs of A. fumigatus. A positive correlation (in the order of IDOγ > IDOβ > IDOα) was observed between the inhibitory sensitivity of the IDOs to Asc and the facilitation of their autoxidation by Asc. The FeII–O2 IDO can repeat the dioxygenase reaction as long as it reacts with L‐Trp; however, substrate‐free FeII–O2 IDO is converted into inactive FeIII–IDO by autoxidation. Thus, L‐Trp (which keeps the IDO active) competes with Asc (which inactivates IDO by accelerating autoxidation). This is probably why Asc, which is structurally quite different from L‐Trp, appears to function as a competitive (or mixed‐competitive) inhibitor of IDOs.

Biochemical and kinetic properties of three indoleamine 2,3‐dioxygenases of Aspergillus fumigatus: mechanism of increase in the apparent Km by ascorbate

Aspergillus fumigatus tryptophan metabolic route differently affects host immunity

A Multifaceted Role of Tryptophan Metabolism and Indoleamine 2,3-Dioxygenase Activity in Aspergillus fumigatus–Host Interactions

Inhibition Mechanism of Indoleamine 2, 3-Dioxygenase 1 (IDO1) by Amidoxime Derivatives and Its Revelation in Drug Design: Comparative Molecular Dynamics Simulations

TrpE Feedback Mutants Reveal Roadblocks and Conduits Toward Increasing Secondary Metabolism in Aspergillus Fumigatus

The Transcription Factors AcuK and AcuM Influence Siderophore Biosynthesis of Aspergillus fumigatus

Evaluation and Comparison of the Commonly Used Bioassays of Human Indoleamine 2,3-Dioxygenase 1 (IDO1) and Tryptophan 2,3-Dioxygenase (TDO).

Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1

Genetic Engineering Activates Biosynthesis of Aromatic Fumaric Acid Amides in the Human Pathogen Aspergillus Fumigatus.

Indoleamine 2, 3-Dioxygenase 1 Inhibitory Compounds from Natural Sources

IDO Regulates Macrophage Functions by Inhibiting the CCL2/CCR2 Signaling Pathway in Fungal Keratitis

tpo3 and dur3, Aspergillus fumigatus Plasma Membrane Regulators of Polyamines, Regulate Polyamine Homeostasis and Susceptibility to Itraconazole

High oxygen tension increases itaconic acid accumulation, glucose consumption, and the expression and activity of alternative oxidase in Aspergillus terreus

Paralogous FgIDO genes with differential roles in tryptophan catabolism, fungal development and virulence in Fusarium graminearum

ONIOM Study on a Missing Piece in Our Understanding of Heme Chemistry: Bacterial Tryptophan 2,3-Dioxygenase with Dual Oxidants.

Purification and Characterization of Ornithine Decarboxylase from Aspergillus terreus; Kinetics of Inhibition by Various Inhibitors

Structure-Activity Relationship and Enzyme Kinetic Studies on 4-Aryl-1h-1,2, 3-Triazoles As Indoleamine 2,3-Dioxygenase (ido) Inhibitors

Design, Synthesis And Biological Evaluation Of Novel 1,2,5-Oxadiazol-3-Carboximidamide Derivatives As Indoleamine 2, 3-Dioxygenase 1 (Ido1) Inhibitors

Research of the new indoleamine 2,3-dioxygenase inhibitors and its treatment of human diseases

Compared D-amino Acid Oxidase Expression in Different Pichia Pastoris Host Strains

Inhibition of Indoleamine 2,3-Dioxygenase Enhances the T-cell Response to Influenza Virus Infection.